IT HAS LONG been assumed that a high cerebrospinal fluid protein conce
ntration adversely affects the performance of shunts. There is little
experimental evidence to support this viewpoint, however, and the few
reports that have been published can be criticized for poor experiment
al design or presentation of results. A flow-dependent shunt perfusion
model was constructed. PS Medical Flow Control valves (PS Medical Cor
poration, Goleta, CA) and Cordis-Hakim valves (Cordis Corporates, Miam
i, FL) were perfused with saline-plasma solutions in concentrations fr
om 0 to 9 g/L of protein. Blood suspensions in dilutions from 0.25 to
1% were also studied. The opening and closing pressures of the valves
were measured with a simple manometer, and the physical properties of
the solutions were studied. The results indicated that the valves perf
ormed within the ranges specified by their manufacturers, even with ma
rkedly increased protein concentrations in the perfusate. Furthermore,
the valve opening and closing pressures were lower with the protein-c
ontaining solutions than with the control solutions. Thus, the protein
did not impair shunt function and we conclude that shunts can be inse
rted into patients who have elevated cerebrospinal fluid protein conte
nts. However, blood cells did adversely affect performance and, theref
ore, patients with hemorrhagic cerebrospinal fluid should not receive
shunts.